Industry groups praised the bill introduced Thursday by Sens. Michael Bennet (D-Colo.) and Orrin Hatch (R-Utah) that would exempt low-risk medical software and mobile apps from FDA regulation and provide greater regulatory certainty. The Medical Electronic Data Technology Enhancement for Consumers’ Health, or MEDTECH, Act joins a handful of other bills that would restrain FDA’s regulatory powers in the health IT domain. The act’s language is more focused than other Senate and House measures, and Hatch’s prominence and history of health care legislation immediately pushed the bill to the fore. Also, the MEDTECH Act hews more closely to the risk-based approach taken last spring by the FDA Safety Innovation Act work group. Its key element concerns clinical decision support software, which is often part of electronic health records and provides prompts to physicians based on research-based algorithms.